China Medical System Holdings Limited (FRA:2M7C)

Germany flag Germany · Delayed Price · Currency is EUR
1.450
-0.030 (-2.03%)
Last updated: Jul 30, 2025
-2.03%
Market Cap3.59B
Revenue (ttm)988.38M
Net Income (ttm)214.35M
Shares Outn/a
EPS (ttm)0.09
PE Ratio16.75
Forward PE17.80
Dividend0.03 (2.33%)
Ex-Dividend DateApr 28, 2025
Volumen/a
Average Volume436
Open1.450
Previous Close1.480
Day's Range1.450 - 1.450
52-Week Range0.710 - 1.490
Betan/a
RSI65.31
Earnings DateAug 18, 2025

About Smartsheet

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China. The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam nasal spray for seizure clusters; XinHuoSu, a recombinant human brain natriuretic peptide for acute heart failure; Plendil, a felodipine sustained release tablets for hypertension; and Deanxit, a flupentixol and melitracen tablets for mild-to-moderate ... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 6,141
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 2M7C
Full Company Profile

Financial Performance

In 2024, FRA:2M7C's revenue was 7.47 billion, a decrease of -6.79% compared to the previous year's 8.01 billion. Earnings were 1.62 billion, a decrease of -32.54%.

Financial Statements

News

There is no news available yet.